Nice, Provence-Alpes-Côte d'Azur, France
For 25 years, I have been building HOEFMAN Laboratoires with conviction and execution, from a single idea to a presence in 30 countries across Africa. We are structuring a new approach to fertility, not only for women, but for the couple. With VIVAGEST® (pregnancy & fertility support) and ALPHA HOM (male fertility & vitality), we are moving from isolated products to an integrated fertility ecosystem. Today, VIVAGEST® is active in 30 countries across Africa, scaling towards Europe. Our IP portfolio covers 74 countries across 5 continents. What we are building is not a product. It is a global reproductive health platform, designed to scale from nutraceuticals to pharmaceuticals, from distribution to licensing deals with global pharma partners. Our next frontier: endometriosis. 300 million women suffer from it every day. The diagnosis takes 7 to 10 years on average. We are building the solution, with Professor Michele Zuckermann, CMO, 200+ scientific publications, 40 years of surgical expertise, now fully dedicated to women's health. Patient-Centered. Science-Driven. Built for impact. If you are a VC, a licensing partner, a pharma innovator, or a researcher in women's health — this is where the conversation starts. Scaling by Healing www.hoefman-laboratoires.com | www.vivagest.com | www.alphahom.com